De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle (CHORAL) (CHORAL)
Primary Purpose
Mortality, Oral Health, Dryness, Mouth
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Chlorhexidine Mouth Rinse
Chlorhexidine Mouth Rinse De-Adoption
Sponsored by
About this trial
This is an interventional prevention trial for Mortality
Eligibility Criteria
Inclusion Criteria:
- All patients who receive mechanical ventilation in the participating ICUs.
Exclusion Criteria:
- Does not meet inclusion criteria.
Sites / Locations
- Mount Sinai Hospital
- St. Michael's Hospital
- Sunnybrook Health Sciences Centre
- Toronto General Hospital
- Toronto Western Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Experimental
Arm Label
Oral Chlorhexidine Mouth Rinse
De-Adoption of Oral Chlorhexidine Mouth Rinse
Arm Description
Application of chlorhexidine gluconate mouth rinse per unit protocol.
No application of chlorhexidine gluconate mouth rinse. Oral care bundle.
Outcomes
Primary Outcome Measures
Intensive Care Unit (ICU) Mortality
All-cause mortality at time of ICU discharge
Secondary Outcome Measures
Infection-related ventilator-associated complications (IVACs)
Changes in IVACs rates between groups
Beck Oral Assessment Score (BOAS), Modified
Changes in oral health between groups. Scores range from 5 (normal) to 20 (severe dysfunction).
Critical Care Pain Observational Tool (CPOT)
Changes in oropharyngeal pain between groups. CPOT scores range from 0-8 with a score >2 indicating presence of pain.
Oral Dryness - Numeric Rating Intensity Scale (NRS)
Changes in oral dryness scores between groups. NRS scores range from 0 (no dryness) to 10 (severe dryness).
Full Information
NCT ID
NCT03382730
First Posted
October 19, 2017
Last Updated
May 3, 2022
Sponsor
University of Toronto
Collaborators
Sunnybrook Health Sciences Centre, Toronto General Hospital, University Health Network, Toronto, Unity Health Toronto, MOUNT SINAI HOSPITAL
1. Study Identification
Unique Protocol Identification Number
NCT03382730
Brief Title
De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle (CHORAL)
Acronym
CHORAL
Official Title
A Multi-centered Stepped Wedge Cluster Randomized Controlled Trial of the De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle for Ventilated Critically Ill Patients
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
December 1, 2017 (Actual)
Primary Completion Date
January 31, 2019 (Actual)
Study Completion Date
January 1, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Toronto
Collaborators
Sunnybrook Health Sciences Centre, Toronto General Hospital, University Health Network, Toronto, Unity Health Toronto, MOUNT SINAI HOSPITAL
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of the CHORAL study is to evaluate the de-adoption of oral chlorhexidine and the introduction of a bundle of oral care practices on selected outcomes in critically ill mechanically ventilated adults.
Detailed Description
Infrequent or ineffective oral care can lead to mouth discomfort and lung infection for patients treated with ventilators (breathing machines) in intensive care units (ICUs). A commonly used mouthwash called chlorhexidine can reduce lung infection but most recent evidence shows it may increase the risk of death. In this study 6 participating intensive care units (ICUs) will de-adopt oral chlorhexidine and introduce a bundle of oral care practices using a multi-faceted educational tool kit. The investigators will measure changes in patient-oriented outcomes including mortality, ventilator-associated complications (VACs) and oral health status. A concurrent process evaluation will study how the intervention is delivered and received by patients and clinicians..
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mortality, Oral Health, Dryness, Mouth, Pain, Orofacial
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Multi-centered stepped wedge cluster randomized controlled trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
3260 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Oral Chlorhexidine Mouth Rinse
Arm Type
Other
Arm Description
Application of chlorhexidine gluconate mouth rinse per unit protocol.
Arm Title
De-Adoption of Oral Chlorhexidine Mouth Rinse
Arm Type
Experimental
Arm Description
No application of chlorhexidine gluconate mouth rinse. Oral care bundle.
Intervention Type
Other
Intervention Name(s)
Chlorhexidine Mouth Rinse
Other Intervention Name(s)
Chlorhexidine
Intervention Description
Oral chlorhexidine gluconate oral rinse
Intervention Type
Other
Intervention Name(s)
Chlorhexidine Mouth Rinse De-Adoption
Other Intervention Name(s)
De-adopt chlorhexidine
Intervention Description
Multifaceted education and audit/feedback.
Primary Outcome Measure Information:
Title
Intensive Care Unit (ICU) Mortality
Description
All-cause mortality at time of ICU discharge
Time Frame
14 months
Secondary Outcome Measure Information:
Title
Infection-related ventilator-associated complications (IVACs)
Description
Changes in IVACs rates between groups
Time Frame
14 months
Title
Beck Oral Assessment Score (BOAS), Modified
Description
Changes in oral health between groups. Scores range from 5 (normal) to 20 (severe dysfunction).
Time Frame
14 months
Title
Critical Care Pain Observational Tool (CPOT)
Description
Changes in oropharyngeal pain between groups. CPOT scores range from 0-8 with a score >2 indicating presence of pain.
Time Frame
14 months
Title
Oral Dryness - Numeric Rating Intensity Scale (NRS)
Description
Changes in oral dryness scores between groups. NRS scores range from 0 (no dryness) to 10 (severe dryness).
Time Frame
14 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients who receive mechanical ventilation in the participating ICUs.
Exclusion Criteria:
Does not meet inclusion criteria.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian Cuthbertson, MD FRCA
Organizational Affiliation
Sunnybrook Health Sciences Centre
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Craig Dale, RN PhD
Organizational Affiliation
Sunnybrook Health Sciences Centre; University of Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mount Sinai Hospital
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
St. Michael's Hospital
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
Sunnybrook Health Sciences Centre
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
Toronto General Hospital
City
Toronto
State/Province
Ontario
Country
Canada
Facility Name
Toronto Western Hospital
City
Toronto
State/Province
Ontario
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
31651364
Citation
Dale CM, Rose L, Carbone S, Smith OM, Burry L, Fan E, Amaral ACK, McCredie VA, Pinto R, Quinonez CR, Sutherland S, Scales DC, Cuthbertson BH. Protocol for a multi-centered, stepped wedge, cluster randomized controlled trial of the de-adoption of oral chlorhexidine prophylaxis and implementation of an oral care bundle for mechanically ventilated critically ill patients: the CHORAL study. Trials. 2019 Oct 24;20(1):603. doi: 10.1186/s13063-019-3673-0.
Results Reference
background
PubMed Identifier
34609548
Citation
Dale CM, Rose L, Carbone S, Pinto R, Smith OM, Burry L, Fan E, Amaral ACK, McCredie VA, Scales DC, Cuthbertson BH. Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial. Intensive Care Med. 2021 Nov;47(11):1295-1302. doi: 10.1007/s00134-021-06475-2. Epub 2021 Oct 5.
Results Reference
result
Learn more about this trial
De-adoption of Oral Chlorhexidine Prophylaxis and Implementation of an Oral Care Bundle (CHORAL)
We'll reach out to this number within 24 hrs